Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients

Neuromuscul Disord. 2015 Oct;25(10):754-7. doi: 10.1016/j.nmd.2015.07.006. Epub 2015 Jul 29.

Abstract

Duchenne muscular dystrophy (DMD) is a progressive muscular disorder in which respiratory and heart failures are the main causes of death. Intensive intervention in respiratory and cardiac function has dramatically improved the prognosis; however, dysfunction in other multiple organs may emerge in the later stages of the disease. We report the case of four non-ambulatory DMD patients who presented with renal failure. Common findings included decreased fluid intake, use of diuretics, and presence of chronic heart failure. The levels of serum cystatin C (CysC), a marker of kidney function unaffected by reduced muscle mass, were elevated in all four patients. In two patients, renal failure improved by increasing fluid intake, and discontinuing or reducing the dose of diuretics. The findings suggest that non-ambulatory DMD patients are at a risk of reduced kidney perfusion, which potentially leads to prerenal failure. Therefore, in DMD patients, dehydration signs and CysC levels should be monitored.

Keywords: Chronic renal hypoperfusion; Cystatin C; Duchenne muscular dystrophy; Non-ambulatory; Renal failure.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Urea Nitrogen
  • Cystatin C / blood
  • Drinking
  • Dystrophin / genetics
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne / blood
  • Muscular Dystrophy, Duchenne / complications*
  • Mutation
  • Renal Insufficiency / blood
  • Renal Insufficiency / complications*
  • Renal Insufficiency / diagnosis*
  • Renal Insufficiency / prevention & control
  • Risk Factors

Substances

  • Cystatin C
  • Dystrophin